Systemic reactions to radiocontrast media (RCM) administration are not
: a rare clinical occurrence. Most of these reactions involve some com
bination of pulmonary, cardiovascular, gastrointestinal, and cutaneous
symptoms that can be life-threatening if not promptly and properly tr
eated. These reactions involve systemic mast cell activation, histamin
e release, but not specific IgE, and are most accurately termed anaphy
lactoid. This article reviews the pathophysiology, clinical presentati
ons, and management of RCM reactions.